News

Eveliqure Biotechnologies announced that further financing has been secured from Arax Capital Partners comprising the last instalment of a €1.7M total…

02 Jul'20

It is long known that the acquired immune system can generate a vast antibody (immunoglobulin) repertoire by gene recombination in developing B-cells.…

29 Jun'20

The proposed function of the centriolar protein Cep97 has to be revised, a new study from the Dammerman lab shows. Rather than just limiting centriole…

24 Jun'20

Scientists from the Vienna BioCenter have pushed SARS-CoV-2 detection to a new level. Their approach is as sensitive and robust, yet cheaper, simpler…

18 Jun'20

Valneva SE and Bavarian Nordic A/S (OMX: BAVA) today announced that they have signed a binding term sheet to establish a partnership for the marketing…

15 Jun'20

Batavia Biosciences and Valneva Sweden AB, the Swedish subsidiary of Valneva SE announced that they have entered into a collaboration agreement to…

09 Jun'20

Valneva announced that the antitrust-related condition precedent for its Lyme vaccine collaboration agreement with Pfizer has been met. As a result,…

08 Jun'20

Researchers at IMBA and IMP develop a new CRISPR tool that predicts effective guide RNAs with unprecedented precision. They named it Vienna…

04 Jun'20

CEBINA announced that it has received seed funding for its extended spectrum Coronavirus vaccine project, which is part of CEBINA’s broad-scale…

04 Jun'20

Eveliqure Biotechnologies has announced that the Hungarian regulatory agency OGYÈI has approved the clinical trial for its vaccine program to prevent…

03 Jun'20

Valneva announced the publication of full data from the Phase 1 clinical trial of its chikungunya vaccine candidate, VLA1553, in the peer-reviewed…

02 Jun'20

Researchers from the lab of Florian Raible at the Max Perutz Labs and their collaborators have developed an improved tissue clearing and…

Eveliqure secures further private investment to support development of its combined Shigella and ETEC vaccine candidate

How the immune system generates a vast antibody repertoire to fight infections

Cep97: a stabilizing protein roof for centrioles

Researchers develop a "quick and easy" Covid-19 test for population screening with simple means

Valneva and Bavarian Nordic Announce Marketing and Distribution Partnership

Batavia Biosciences and Valneva Collaborate to Accelerate Development of Low-cost Inactivated Polio Vaccine

Valneva announces HSR clearance for Lyme vaccine collaboration with Pfizer

New prediction tool sharpens the CRISPR scissors

CEBINA secures seed funding for its unique extended spectrum Coronavirus vaccine

Eveliqure announces regulatory approval to commence first clinical studies with its combined Shigella and ETEC vaccine

Valneva Announces Publication in The Lancet of Complete Phase 1 Data for its Single-Shot Chikungunya Vaccine Candidate

A “DEEP-Clear” view of nervous system diversity